Communication

Publications

Return

EMCDDA trendspotter briefing May 2020 Impact of COVID-19 on drug services and help-seeking in Europe

EMCDDA trendspotter briefing May 2020 Impact of COVID-19 on drug services and help-seeking in Europe

EMCDDA. European Monitoring Centre for Drugs and Drug Addiction

Since the start of 2020, European countries have been experiencing an unprecedented public health threat with the emergence of the coronavirus disease (COVID-19). In order to investigate the effects and implications of this outbreak for drug services in Europe, the European Monitoring Centre for Drugs and Drug Addiction instigated a mixed-method trendspotter study to provide a snapshot of the current situation. This exercise provides a rapid assessment of the state of play in respect to the impact of COVID-19 on service provision and help-seeking behaviour among people who use drugs.

Access

The European Commission is preparing a third phase of this programme, therefore COPOLAD will be back at the beginning of 2021.